The DOI matches its Crossref record; 99 of the 99 references it cites were found in a registry or an index.
Chemokine receptor antagonists: overcoming developmental hurdles
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bradford, M. M. (1976) · Analytical Biochemistry · doi:10.1016/0003-2697(76)90527-3 · Cited by 255,302
International Union of Pharmacology: Approaches to the Nomenclature of Voltage-Gated Ion Channels
Catterall, W. A., Chandy, K. G., Clapham, D. E., Gutman, G. A., Hofmann, F., Harmar, A. J., Abernethy, D. R., & Spedding, M. (2003) · Pharmacological Reviews · doi:10.1124/pr.55.4.5 · Cited by 7,126
HIV-1 Entry Cofactor: Functional cDNA Cloning of a Seven-Transmembrane, G Protein-Coupled Receptor
Feng, Y., Broder, C. C., Kennedy, P. E., & Berger, E. A. (1996) · Science · doi:10.1126/science.272.5263.872 · Cited by 4,172
Zlotnik, A., & Yoshie, O. (2000) · Immunity · doi:10.1016/s1074-7613(00)80165-x · Cited by 3,859
How many drug targets are there?
Overington, J. P., Al-Lazikani, B., & Hopkins, A. L. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd2199 · Cited by 3,505
Hopkins, A. L., & Groom, C. R. (2002) · Nature Reviews Drug Discovery · doi:10.1038/nrd892 · Cited by 3,305
Fredriksson, R., Lagerström, M. C., Lundin, L.-G., & Schiöth, H. B. (2003) · Molecular Pharmacology · doi:10.1124/mol.63.6.1256 · Cited by 2,941
Noseworthy, J. H., Lucchinetti, C., Rodriguez, M., & Weinshenker, B. G. (2000) · New England Journal of Medicine · doi:10.1056/nejm200009283431307 · Cited by 2,899
Cocchi, F., DeVico, A. L., Garzino-Demo, A., Arya, S. K., Gallo, R. C., & Lusso, P. (1995) · Science · doi:10.1126/science.270.5243.1811 · Cited by 2,869
Chemokines and leukocyte traffic
Baggiolini, M. (1998) · Nature · doi:10.1038/33340 · Cited by 2,709
The many roles of chemokines and chemokine receptors in inflammation
Charo, I. F., & Ransohoff, R. M. (2006) · New England Journal of Medicine · doi:10.1056/nejmra052723 · Cited by 2,523
International Union of Pharmacology. XXII. Nomenclature for Chemokine Receptors
Murphy, P. M., Baggiolini, M., Charo, I. F., Hébert, C. A., Horuk, R., Matsushima, K., Miller, L. H., Oppenheim, J. J., & Power, C. A. (2000) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01439-x · Cited by 1,817
Self-citationGerard, C., & Rollins, B. J. (2001) · Nature Immunology · doi:10.1038/84209 · Cited by 1,357
Ji, T. H., Grossmann, M., & Ji, I. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.28.17299 · Cited by 1,277
Roth, B. L., Sheffler, D. J., & Kroeze, W. K. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1346 · Cited by 1,155
Dorr, P., Westby, M., Dobbs, S., Griffin, P., Irvine, B., Macartney, M., Mori, J., Rickett, G., Smith-Burchnell, C., Napier, C., et al. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.11.4721-4732.2005 · Cited by 1,152
A small-molecule, nonpeptide CCR5 antagonist with highly potent and selective anti-HIV-1 activity
Baba, M., Nishimura, O., Kanzaki, N., Okamoto, M., Sawada, H., Iizawa, Y., Shiraishi, M., Aramaki, Y., Okonogi, K., Ogawa, Y., et al. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.10.5698 · Cited by 751
From magic bullets to designed multiple ligands
Morphy, R., Kay, C., & Rankovic, Z. (2004) · Drug Discovery Today · doi:10.1016/s1359-6446(04)03163-0 · Cited by 729
The Organic Chemistry of Drug Design and Drug Action
(1992) · Elsevier eBooks · doi:10.1016/c2009-0-22221-5 · Cited by 712
Charo, I. F., Myers, S. J., Herman, A., Franci, C., Connolly, A. J., & Coughlin, S. R. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.7.2752 · Cited by 705
Heterogeneity of multiple sclerosis pathogenesis: implications for diagnosis and therapy
Lassmann, H., Brück, W., & Lucchinetti, C. (2001) · Trends in Molecular Medicine · doi:10.1016/s1471-4914(00)01909-2 · Cited by 627
Requirement of the Chemokine Receptor CXCR3 for Acute Allograft Rejection
Hancock, W. W., Lu, B., Gao, W., Csizmadia, V., Faia, K., King, J. A., Smiley, S. T., Ling, M., Gerard, N. P., & Gerard, C. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.192.10.1515 · Cited by 617
Fätkenheuer, G., Pozniak, A. L., Johnson, M. A., Plettenberg, A., Staszewski, S., Hoepelman, A. I. M., Saag, M. S., Goebel, F. D., Rockstroh, J. K., Dezube, B. J., et al. (2005) · Nature Medicine · doi:10.1038/nm1319 · Cited by 495
Karpus, W. J., Lukacs, N. W., McRae, B. L., Strieter, R. M., Kunkel, S. L., & Miller, S. D. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.155.10.5003 · Cited by 482
Loetscher, P., Seitz, M., Baggiolini, M., & Moser, B. (1996) · The Journal of experimental medicine · doi:10.1084/jem.184.2.569 · Cited by 417
Taylor, P. C., Peters, A. M., Paleolog, E., Chapman, P. T., Elliott, M. J., McCloskey, R., Feldmann, M., & Maini, R. N. (2000) · Arthritis & Rheumatism · doi:10.1002/1529-0131(200001)43:1<38::aid-anr6>3.0.co;2-l · Cited by 405
Protection from Pulmonary Fibrosis in the Absence of CCR2 Signaling
Moore, B. B., Paine, R., Christensen, P. J., Moore, T. A., Sitterding, S., Ngan, R., Wilke, C. A., Kuziel, W. A., & Toews, G. B. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.8.4368 · Cited by 371
Flier, J., Boorsma, D. M., van Beek, P. J., Nieboer, C., Stoof, T. J., Willemze, R., & Tensen, C. P. (2001) · The Journal of Pathology · doi:10.1002/1096-9896(200108)194:4<397::aid-path899>3.0.co;2-s · Cited by 363
Chemokine/Chemokine Receptor Nomenclature
(2002) · Journal of Interferon & Cytokine Research · doi:10.1089/107999002760624305 · Cited by 353
Horuk, R. (2001) · Cytokine & Growth Factor Reviews · doi:10.1016/s1359-6101(01)00014-4 · Cited by 344
Self-citationFrantz, S. (2005) · Nature · doi:10.1038/437942a · Cited by 322
Karpus, W. J., & Kennedy, K. J. (1997) · Journal of Leukocyte Biology · doi:10.1002/jlb.62.5.681 · Cited by 306
Watson, C., Jenkinson, S., Kazmierski, W., & Kenakin, T. (2005) · Molecular Pharmacology · doi:10.1124/mol.104.008565 · Cited by 302
The Organic Chemistry of Drug Design and Drug Action
Cooper, M. E. (2004) · Drug Discovery Today · doi:10.1016/s1359-6446(04)03199-x · Cited by 292
Esté, J. A., & Telenti, A. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61052-6 · Cited by 287
Katschke, K. J., Rottman, J. B., Ruth, J. H., Qin, S., Wu, L., LaRosa, G., Ponath, P., Park, C. C., Pope, R. M., & Koch, A. E. (2001) · Arthritis & Rheumatism · doi:10.1002/1529-0131(200105)44:5<1022::aid-anr181>3.0.co;2-n · Cited by 286
Sica, A., Saccani, A., Borsatti, A., Power, C. A., Wells, T. N. C., Luini, W., Polentarutti, N., Sozzani, S., & Mantovani, A. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.185.5.969 · Cited by 280
Lambeir, A.-M., Proost, P., Durinx, C., Bal, G., Senten, K., Augustyns, K., Scharpé, S., Van Damme, J., & De Meester, I. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m103106200 · Cited by 271
Virtues and pitfalls of EAE for the development of therapies for multiple sclerosis
Steinman, L., & Zamvil, S. S. (2005) · Trends in Immunology · doi:10.1016/j.it.2005.08.014 · Cited by 265
Haringman, J. J., Gerlag, D. M., Smeets, T. J. M., Baeten, D., van den Bosch, F., Bresnihan, B., Breedveld, F. C., Dinant, H. J., Legay, F., Gram, H., et al. (2006) · Arthritis & Rheumatism · doi:10.1002/art.21975 · Cited by 258
Trebst, C., Lykke Sørensen, T., Kivisäkk, P., Cathcart, M. K., Hesselgesser, J., Horuk, R., Sellebjerg, F., Lassmann, H., & Ransohoff, R. M. (2001) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63017-9 · Cited by 242
Self-citationVergunst, C. E., Gerlag, D. M., Lopatinskaya, L., Klareskog, L., Smith, M. D., van den Bosch, F., Dinant, H. J., Lee, Y., Wyant, T., Jacobson, E. W., et al. (2008) · Arthritis & Rheumatism · doi:10.1002/art.23591 · Cited by 236
Haringman, J. J., Smeets, T. J. M., Reinders-Blankert, P., & Tak, P. P. (2006) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2005.037176 · Cited by 227
A Small Molecule Antagonist of Chemokine Receptors CCR1 and CCR3
Sabroe, I., Peck, M. J., Van Keulen, B. J., Jorritsma, A., Simmons, G., Clapham, P. R., Williams, T. J., & Pease, J. E. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m908864199 · Cited by 219
Haringman, J. J., Kraan, M. C., Smeets, T. J. M., Zwinderman, K. H., & Tak, P. P. (2003) · Annals of the Rheumatic Diseases · doi:10.1136/ard.62.8.715 · Cited by 217
A chemokine receptor CCR-1 antagonist reduces renal fibrosis after unilateral ureter ligation
Anders, H.-J., Vielhauer, V., Frink, M., Linde, Y., Cohen, C. D., Blattner, S. M., Kretzler, M., Strutz, F., Mack, M., Gröne, H.-J., et al. (2002) · Journal of Clinical Investigation · doi:10.1172/jci14040 · Cited by 207
Self-citationLiang, M., Mallari, C., Rosser, M., Ng, H. P., May, K., Monahan, S., Bauman, J. G., Islam, I., Ghannam, A., Buckman, B., et al. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m001222200 · Cited by 206
Self-citationIdentification of the Glycosaminoglycan Binding Site of the CC Chemokine, MCP-1
Lau, E. K., Paavola, C. D., Johnson, Z., Gaudry, J.-P., Geretti, E., Borlat, F., Kungl, A. J., Proudfoot, A. E., & Handel, T. M. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m311224200 · Cited by 204
Leukocyte recruitment during onset of experimental allergic encephalomyelitis is CCR1 dependent
Rottman, J. B., Slavin, A. J., Silva, R., Weiner, H. L., Gerard, C. G., & Hancock, W. W. (2000) · European Journal of Immunology · doi:10.1002/1521-4141(2000)30:8<2372::aid-immu2372>3.0.co;2-d · Cited by 204
Chemokine/chemokine receptor nomenclature
(2003) · Cytokine · doi:10.1016/s1043-4666(02)00493-3 · Cited by 198
Evidence for Negative Binding Cooperativity within CCR5-CCR2b Heterodimers
El-Asmar, L., Springael, J.-Y., Ballet, S., Andrieu, E. U., Vassart, G., & Parmentier, M. (2005) · Molecular Pharmacology · doi:10.1124/mol.104.003624 · Cited by 195
Eotaxin is a natural antagonist for CCR2 and an agonist for CCR5
Ogilvie, P., Bardi, G., Clark-Lewis, I., Baggiolini, M., & Uguccioni, M. (2001) · Blood · doi:10.1182/blood.v97.7.1920 · Cited by 187
Therapeutic Approaches in Multiple Sclerosis: Lessons from Failed and Interrupted Treatment Trials
Wiendl, H., & Hohlfeld, R. (2002) · BioDrugs · doi:10.2165/00063030-200216030-00003 · Cited by 183
A chemokine receptor CCR-1 antagonist reduces renal fibrosis after unilateral ureter ligation
Anders, H.-J., Vielhauer, V., Frink, M., Linde, Y., Cohen, C. D., Blattner, S. M., Kretzler, M., Strutz, F., Mack, M., Gröne, H.-J., et al. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0214040 · Cited by 183
Self-citationChemokines and their receptors in allograft rejection
Hancock, W. W., Gao, W., Faia, K. L., & Csizmadia, V. (2000) · Current Opinion in Immunology · doi:10.1016/s0952-7915(00)00130-8 · Cited by 182
OGATA, H., TAKEYA, M., YOSHIMURA, T., TAKAGI, K., & TAKAHASHI, K. (1997) · The Journal of Pathology · doi:10.1002/(sici)1096-9896(199705)182:1<106::aid-path816>3.0.co;2-a · Cited by 173
Xie, J. H., Nomura, N., Lu, M., Chen, S.-L., Koch, G. E., Weng, Y., Rosa, R., Di Salvo, J., Mudgett, J., Peterson, L. B., et al. (2003) · Journal of Leukocyte Biology · doi:10.1189/jlb.1102573 · Cited by 167
BENEFICIAL EFFECTS OF TARGETING CCR5 IN ALLOGRAFT RECIPIENTS1
Gao, W., Faia, K. L., Csizmadia, V., Smiley, S. T., Soler, D., King, J. A., Danoff, T. M., & Hancock, W. W. (2001) · Transplantation · doi:10.1097/00007890-200110150-00003 · Cited by 164
Misbehaving macrophages in the pathogenesis of psoriasis
Clark, R. A. (2006) · Journal of Clinical Investigation · doi:10.1172/jci29441 · Cited by 158
Blanpain, C., Doranz, B. J., Bondue, A., Govaerts, C., Leener, A. D., Vassart, G., Doms, R. W., Proudfoot, A. E. J., & Parmentier, M. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m205684200 · Cited by 157
Amino-terminally Modified RANTES Analogues Demonstrate Differential Effects on RANTES Receptors
Proudfoot, A. E. I., Buser, R., Borlat, F., Alouani, S., Soler, D. F., Offord, R. E., Schröder, J.-M., Power, C., & Wells, T. N. C. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.45.32478 · Cited by 153
Hesselgesser, J., Ng, H. P., Liang, M., Zheng, W., May, K. E., Bauman, J. G., Monahan, S. D., Islam, I., Guo, W., Ghannam, A. F., et al. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.25.15687 · Cited by 152
Self-citationChapman, R. W., Minnicozzi, M., Celly, C. S., Phillips, J. E., Kung, T. T., Hipkin, R. W., Fan, X., Rindgen, D., Deno, G., Bond, R. W., et al. (2007) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.106.119040 · Cited by 148
Cytokine reference : a compendium of cytokines and other mediators of host defence
Durum, S. K., Oppenheim, J. J., Feldmann, M., Hirano, T., Vilec, J., & Nicola, N. A. (2001) · Academic Press eBooks · Cited by 145
Pharmacological Characterization of Sch527123, a Potent Allosteric CXCR1/CXCR2 Antagonist
Gonsiorek, W., Fan, X., Hesk, D., Fossetta, J. D., Qiu, H., Jakway, J. P., Billah, M. M., Dwyer, M. P., Chao, J., Deno, G., et al. (2007) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.106.118927 · Cited by 130
Is there a ‘lock’ for all agonist ‘keys’ in 7TM receptors?
Schwartz, T. W., & ROSENKILDE, M. M. (1996) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(96)10017-1 · Cited by 130
2-Arylpropionic CXC Chemokine Receptor 1 (CXCR1) Ligands as Novel Noncompetitive CXCL8 Inhibitors
Allegretti, M., Bertini, R., Cesta, M. C., Bizzarri, C., Bitondo, R. D., Cioccio, V. D., Galliera, E., Berdini, V., Topai, A., Zampella, G., et al. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm049082i · Cited by 129
Steinman, L. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.194.5.f27 · Cited by 123
Dwyer, M. P., Yu, Y., Chao, J., Aki, C., Chao, J., Biju, P., GIRIJAVALLABHAN, V. M., Rindgen, D., Bond, R. W., Mayer-Ezel, R., et al. (2006) · Journal of Medicinal Chemistry · doi:10.1021/jm0609622 · Cited by 120
Weber, M., Uguccioni, M., Baggiolini, M., Clark‐Lewis, I., & Dahinden, C. A. (1996) · The Journal of Experimental Medicine · doi:10.1084/jem.183.2.681 · Cited by 116
Discovery and optimization of a series of quinazolinone-derived antagonists of CXCR3
Johnson, M., Li, A., Liu, J., Fu, Z., Zhu, L., Miao, S., Wang, X., Xu, Q., Huang, A., Marcus, A. P., et al. (2007) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2007.03.106 · Cited by 107
Vaidehi, N., Schlyer, S., Trabanino, R. J., Floriano, W. B., Abrol, R., Sharma, S. K., Kochanny, M. J., Koovakat, S., Dunning, L., Liang, M., et al. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m601389200 · Cited by 100
Self-citationVilla, P., Triulzi, S., Cavalieri, B., Bitondo, R. D., Bertini, R., Barbera, S., Bigini, P., Mennini, T., Gelosa, P., Tremoli, E., et al. (2007) · Molecular Medicine · doi:10.2119/2007-00008.villa · Cited by 92
Murugesan, N., Gu, Z., Fadnis, L., Tellew, J. E., Baska, R. A. F., Yang, Y., Beyer, S. M., Monshizadegan, H., Dickinson, K. E. J., Valentine, M. T., et al. (2004) · Journal of Medicinal Chemistry · doi:10.1021/jm049548x · Cited by 91
Seto, M., Aikawa, K., Miyamoto, N., Aramaki, Y., Kanzaki, N., Takashima, K., Kuze, Y., Iizawa, Y., Baba, M., & Shiraishi, M. (2006) · Journal of Medicinal Chemistry · doi:10.1021/jm0509703 · Cited by 91
Gladue, R. P., Tylaska, L. A., Brissette, W. H., Lira, P. D., Kath, J. C., Poss, C. S., Brown, M. F., Paradis, T. J., Conklyn, M. J., Ogborne, K. T., et al. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m306875200 · Cited by 90
Drugs: from discovery to approval
(2004) · Choice Reviews Online · doi:10.5860/choice.41-6569 · Cited by 84
Angiogenesis in Rheumatoid Arthritis: Pathogenic and Clinical Significance
Szekanecz, Z., Szegedi, G. Y., & Ae, K. (1998) · Journal of Investigative Medicine · doi:10.1177/108155899804600207 · Cited by 82
Pharmacological blockade of CCR1 ameliorates murine arthritis and alters cytokine networksin vivo
Amat, M., Benjamim, C. F., Williams, L., et al. (2006) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706912 · Cited by 81
Widney, D. P., Xia, Y.-R., Lusis, A. J., & Smith, J. B. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.12.6322 · Cited by 80
Blockade of chemokine signaling in patients with multiple sclerosis
Zipp, F., Hartung, H., Hillert, J. A., Schimrigk, S., Trebst, C., Stangel, M., Infante‐Duarte, C., Jakobs, P., Wolf, C., Sandbrink, R., et al. (2006) · Neurology · doi:10.1212/01.wnl.0000244420.68037.86 · Cited by 80
Dijkstra, C. D., van der Voort, E. R., Groot, C. J. A. D., et al. (1994) · Psychoneuroendocrinology · doi:10.1016/0306-4530(94)90003-5 · Cited by 73
de Mendonça, F. L., da Fonseca, P. C. A., Phillips, R. M., Saldanha, J. W., Williams, T. J., & Pease, J. E. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m412267200 · Cited by 65
Evaluation of a series of bicyclic CXCR2 antagonists
Walters, I. A. S., Austin, C. A., Austin, R. P., Bonnert, R. V., Cage, P. A., Christie, M. I., Ebden, M. R., Gardiner, S. D., Grahames, C., Hill, S., et al. (2007) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2007.11.039 · Cited by 63
Combined CXCR3/CCR5 Blockade Attenuates Acute and Chronic Rejection
Schnickel, G. T., Bastani, S., Hsieh, G. R., Shefizadeh, A., Bhatia, R., Fishbein, M. C., Belperio, J. A., & Ardehali, A. A. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.7.4714 · Cited by 62
Giorelli, M., Livrea, P., & Trojano, M. (2005) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2005.25.395 · Cited by 60
Boehncke, W., & Schön, M. P. (2007) · Clinics in Dermatology · doi:10.1016/j.clindermatol.2007.08.014 · Cited by 56
Gladue, R. P., Cole, S. H., Roach, M. L., Tylaska, L. A., Nelson, R. T., Shepard, R. M., McNeish, J. D., Ogborne, K. T., & Neote, K. S. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.5.3141 · Cited by 55
Chemokine receptor expression in rat adjuvant‐induced arthritis
Haas, C. S., Martinez, R. J., Attia, N., Haines, G. K., Campbell, P. L., & Koch, A. E. (2005) · Arthritis & Rheumatism · doi:10.1002/art.21476 · Cited by 49
Eltayeb, S., Sunnemark, D., Berg, A., Nordvall, G., Malmberg, Å., Lassmann, H., Wallström, E., Olsson, T. P., & Ericsson‐Dahlstrand, A. (2003) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(03)00264-9 · Cited by 46
Chemokine inhibition in inflammatory arthritis
Tak, P. P. (2006) · Best Practice & Research Clinical Rheumatology · doi:10.1016/j.berh.2006.06.001 · Cited by 45
Conformationally Restricted Indolopiperidine Derivatives as Potent CCR2B Receptor Antagonists
Witherington, J. J., Bordas, V., Cooper, D. G., Forbes, I. T., Gribble, A. D., Ife, R. J., Berkhout, T. A., Gohil, J., & Groot, P. H. E. (2001) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(01)00397-3 · Cited by 44
EAE: pitfalls outweigh virtues of screening potential treatments for multiple sclerosis
Ransohoff, R. M. (2006) · Trends in Immunology · doi:10.1016/j.it.2006.02.007 · Cited by 42
Ellingsen, T., Hornung, N., Moller, B. K., Poulsen, J. H., & Stengaard‐Pedersen, K. (2006) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2006.054056 · Cited by 42
Chapter 14 Advances in the Discovery of CC Chemokine Receptor 2 Antagonists
Carter, P. H., Cherney, R. J., & Mangion, I. K. (2007) · Annual reports in medicinal chemistry · doi:10.1016/s0065-7743(07)42014-0 · Cited by 23
Braddock, M. (2007) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.16.6.909 · Cited by 20
Chemokine Biology — Basic Research and Clinical Application
Neote, K. S., Moser, B., & Letts, G. L. (2007) · Birkhäuser Basel eBooks · doi:10.1007/978-3-7643-7437-2 · Cited by 16
Piperazinyl CCR1 antagonists—optimization of human liver microsome stability
Brown, M. F., Bahnck, K. B., Blumberg, L. C., Brissette, W. H., Burrell, S. A., Driscoll, J. P., Fedeles, F., Fisher, M. B., Foti, R., Gladue, R. P., et al. (2007) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2007.03.037 · Cited by 13
Advances in Anti-Inflammatory Therapeutics
Braddock, M. (2007) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.16.2.257 · Cited by 11
Cited by
Osteoarthritis: toward a comprehensive understanding of pathological mechanism
Chen, D., Shen, J., Zhao, W., Wang, T., Han, L., Hamilton, J. L., & Im, H.-J. (2017) · Bone Research · doi:10.1038/boneres.2016.44 · Cited by 1,187
Neutrophil migration in infection and wound repair: going forward in reverse
de Oliveira, S., Rosowski, E. E., & Huttenlocher, A. (2016) · Nature Reviews Immunology · doi:10.1038/nri.2016.49 · Cited by 1,058
Bachelerie, F., Ben-Baruch, A., Burkhardt, A. M., Combadiere, C., Farber, J. M., Graham, G. J., Horuk, R., Sparre-Ulrich, A. H., Locati, M., Luster, A. D., et al. (2014) · Pharmacological Reviews · doi:10.1124/pr.113.007724 · Cited by 850
Self-citationLi, X., Yao, W., Yuan, Y., Chen, P., Li, B., Li, J., Chu, R., Song, H., Xie, D., Jiang, X., et al. (2017) · Gut · doi:10.1136/gutjnl-2015-310514 · Cited by 737
Chemokines and Chemokine Receptors: New Targets for Cancer Immunotherapy
Mollica Poeta, V., Massara, M., Capucetti, A., & Bonecchi, R. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00379 · Cited by 583
Metadata
- Authors
- Horuk, R.
- Venue
- Nature Reviews Drug Discovery
- Published
- 2008-12-12
- Volume
- 8
- Issue
- 1
- Pages
- 23-33
- ISSN
- 1474-1776 (ISSN-L)
- 1474-1784
- OpenAlex
- W2058189238
- Cited by
- 303
- References
- 99
- FWCI
- 1.28
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.